{"entity":{"type":"insider","cik":"0001354802","url":"/insider/0001354802","json_url":"/insider/0001354802.json","name":"Warden Charles M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":15,"first":"2006-05-15","last":"2016-06-10","span_basis":"filed_date"},"name_variants":[{"name":"Warden Charles M","source":"filing","n_filings":15,"first_seen":"2006-05-15","last_seen":"2016-06-10"}],"transactions":[{"id":2630921,"accession":"0001104659-16-126661","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-126661","line_url":"/filing/0001104659-16-126661","is_derivative":false,"issuer_cik":"0001279592","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001279592","owner_cik":null,"owner_name":"LUBASH BARBARA N; Bolzon Bradley J PhD; Warden Charles M; Praeger Robin L.","owner_display_name":"LUBASH BARBARA N","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":714285.0,"shares_display":"714,285","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":3511670.0,"shares_owned_after_display":"3,511,670","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-08","filed_date":"2016-06-10","scope":"insider","n_lines":2},{"id":2172863,"accession":"0001144204-16-104561","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-16-104561","line_url":"/filing/0001144204-16-104561","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Bolzon Bradley J PhD; Warden Charles M; ATWOOD BRIAN G","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":258044.0,"shares_display":"258,044","price_per_share":0.01,"price_display":"0.01","price_state":"stated","total_value":2580.44,"total_display":"2,580.44","total_whole":"2,580","shares_owned_after":1334617.0,"shares_owned_after_display":"1,334,617","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider","n_lines":4},{"id":2172844,"accession":"0001144204-16-104561","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-104561","line_url":"/filing/0001144204-16-104561","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"PHASERX, INC.","issuer_ticker":"PZRX","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Bolzon Bradley J PhD; Warden Charles M; ATWOOD BRIAN G","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":1931094.0,"shares_owned_after_display":"1,931,094","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider","n_lines":2},{"id":8785819,"accession":"0001209191-15-053409","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-053409","line_url":"/filing/0001209191-15-053409","is_derivative":false,"issuer_cik":"0001354802","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001354802","owner_cik":"0001354802","owner_name":"Warden Charles M","owner_display_name":"Warden Charles M","owner_url":"/insider/0001354802","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":320000.0,"shares_display":"320,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":7040000.0,"total_display":"7,040,000.00","total_whole":"7,040,000","shares_owned_after":2202377.0,"shares_owned_after_display":"2,202,377","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-15","scope":"insider","n_lines":2},{"id":8943180,"accession":"0001209191-15-052366","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-052366","line_url":"/filing/0001209191-15-052366","is_derivative":false,"issuer_cik":"0001354802","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001354802","owner_cik":"0001354802","owner_name":"Warden Charles M","owner_display_name":"Warden Charles M","owner_url":"/insider/0001354802","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":427000.0,"shares_display":"427,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":9394000.0,"total_display":"9,394,000.00","total_whole":"9,394,000","shares_owned_after":2520499.0,"shares_owned_after_display":"2,520,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-10","filed_date":"2015-06-11","scope":"insider","n_lines":2},{"id":8592910,"accession":"0001209191-15-002482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-002482","line_url":"/filing/0001209191-15-002482#line-1","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"Warden Charles M; Versant Side Fund II, LP; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; LUBASH BARBARA N; Versant Ventures II LLC; Bolzon Bradley J PhD; ROBERTSON REBECCA B","owner_display_name":"Warden Charles M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7946.0,"shares_display":"7,946","price_per_share":30.979,"price_display":"30.98","price_state":"stated","total_value":246159.134,"total_display":"246,159.13","total_whole":"246,159","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-05","filed_date":"2015-01-06","scope":"insider"},{"id":6680995,"accession":"0001209191-14-078193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-078193","line_url":"/filing/0001209191-14-078193#line-1","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; ROBERTSON REBECCA B; Versant Ventures II LLC; Warden Charles M; Bolzon Bradley J PhD; LUBASH BARBARA N; Versant Side Fund II, LP","owner_display_name":"Versant Venture Capital II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9785.0,"shares_display":"9,785","price_per_share":29.7403,"price_display":"29.74","price_state":"stated","total_value":291008.8355,"total_display":"291,008.84","total_whole":"291,009","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-23","filed_date":"2014-12-29","scope":"insider"},{"id":6297468,"accession":"0001209191-14-070176","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-070176","line_url":"/filing/0001209191-14-070176#line-5","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"Versant Side Fund II, LP; Warden Charles M; Versant Ventures II LLC; Bolzon Bradley J PhD; ROBERTSON REBECCA B; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; LUBASH BARBARA N","owner_display_name":"Versant Side Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":24.2162,"price_display":"24.22","price_state":"stated","total_value":84756.7,"total_display":"84,756.70","total_whole":"84,757","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-19","filed_date":"2014-11-19","scope":"insider"},{"id":6297466,"accession":"0001209191-14-070176","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-070176","line_url":"/filing/0001209191-14-070176","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"Versant Side Fund II, LP; Warden Charles M; Versant Ventures II LLC; Bolzon Bradley J PhD; ROBERTSON REBECCA B; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; LUBASH BARBARA N","owner_display_name":"Versant Side Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11848.0,"shares_display":"11,848","price_per_share":24.83224955266712,"price_display":"24.83","price_state":"stated","total_value":294212.4927,"total_display":"294,212.49","total_whole":"294,212","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-18","filed_date":"2014-11-19","scope":"insider","n_lines":2},{"id":6297463,"accession":"0001209191-14-070176","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-070176","line_url":"/filing/0001209191-14-070176","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"Versant Side Fund II, LP; Warden Charles M; Versant Ventures II LLC; Bolzon Bradley J PhD; ROBERTSON REBECCA B; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; LUBASH BARBARA N","owner_display_name":"Versant Side Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12877.0,"shares_display":"12,877","price_per_share":24.872562398074084,"price_display":"24.87","price_state":"stated","total_value":320283.986,"total_display":"320,283.99","total_whole":"320,284","shares_owned_after":7395.0,"shares_owned_after_display":"7,395","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-17","filed_date":"2014-11-19","scope":"insider","n_lines":2},{"id":6977149,"accession":"0001209191-14-069011","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-14-069011","line_url":"/filing/0001209191-14-069011#line-11","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; Versant Side Fund II, LP; Versant Ventures II LLC; ROBERTSON REBECCA B; Warden Charles M; Bolzon Bradley J PhD; LUBASH BARBARA N","owner_display_name":"Versant Venture Capital II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3928.0,"shares_display":"3,928","price_per_share":25.0627,"price_display":"25.06","price_state":"stated","total_value":98446.2856,"total_display":"98,446.29","total_whole":"98,446","shares_owned_after":45912.0,"shares_owned_after_display":"45,912","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2014-11-14","scope":"insider"},{"id":6977146,"accession":"0001209191-14-069011","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-14-069011","line_url":"/filing/0001209191-14-069011#line-10","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; Versant Side Fund II, LP; Versant Ventures II LLC; ROBERTSON REBECCA B; Warden Charles M; Bolzon Bradley J PhD; LUBASH BARBARA N","owner_display_name":"Versant Venture Capital II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5505.0,"shares_display":"5,505","price_per_share":25.1844,"price_display":"25.18","price_state":"stated","total_value":138640.122,"total_display":"138,640.12","total_whole":"138,640","shares_owned_after":49840.0,"shares_owned_after_display":"49,840","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-13","filed_date":"2014-11-14","scope":"insider"},{"id":6848580,"accession":"0001209191-14-067957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-067957","line_url":"/filing/0001209191-14-067957","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"Versant Side Fund II, LP; Warden Charles M; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP; ROBERTSON REBECCA B; Bolzon Bradley J PhD; LUBASH BARBARA N; Versant Ventures II LLC","owner_display_name":"Versant Side Fund II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8637.0,"shares_display":"8,637","price_per_share":24.50982329512562,"price_display":"24.51","price_state":"stated","total_value":211691.3438,"total_display":"211,691.34","total_whole":"211,691","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-10","filed_date":"2014-11-12","scope":"insider","n_lines":2},{"id":9269601,"accession":"0001209191-15-040941","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-040941","line_url":"/filing/0001209191-15-040941#line-2","is_derivative":false,"issuer_cik":"0001279592","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001279592","owner_cik":null,"owner_name":"Bolzon Bradley J PhD; LUBASH BARBARA N; ROBERTSON REBECCA B; Versant Affiliates Fund II-A, LP; Versant Side Fund II, LP; Versant Venture Capital II, LP; Versant Ventures II LLC; Warden Charles M","owner_display_name":"Bolzon Bradley J PhD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3150.0,"shares_display":"3,150","price_per_share":23.9499,"price_display":"23.95","price_state":"stated","total_value":75442.185,"total_display":"75,442.18","total_whole":"75,442","shares_owned_after":55345.0,"shares_owned_after_display":"55,345","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-07","filed_date":"2015-05-11","scope":"insider"},{"id":6531898,"accession":"0001209191-14-067470","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-14-067470","line_url":"/filing/0001209191-14-067470#line-8","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Versant Side Fund II, LP; Bolzon Bradley J PhD; Versant Ventures II LLC; LUBASH BARBARA N; Warden Charles M; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3150.0,"shares_display":"3,150","price_per_share":23.9499,"price_display":"23.95","price_state":"stated","total_value":75442.185,"total_display":"75,442.18","total_whole":"75,442","shares_owned_after":55345.0,"shares_owned_after_display":"55,345","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-07","filed_date":"2014-11-07","scope":"insider"},{"id":9269602,"accession":"0001209191-15-040941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-040941","line_url":"/filing/0001209191-15-040941#line-1","is_derivative":false,"issuer_cik":"0001279592","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001279592","owner_cik":null,"owner_name":"Bolzon Bradley J PhD; LUBASH BARBARA N; ROBERTSON REBECCA B; Versant Affiliates Fund II-A, LP; Versant Side Fund II, LP; Versant Venture Capital II, LP; Versant Ventures II LLC; Warden Charles M","owner_display_name":"Bolzon Bradley J PhD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4238.0,"shares_display":"4,238","price_per_share":24.5617,"price_display":"24.56","price_state":"stated","total_value":104092.4846,"total_display":"104,092.48","total_whole":"104,092","shares_owned_after":58495.0,"shares_owned_after_display":"58,495","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-06","filed_date":"2015-05-11","scope":"insider"},{"id":6531894,"accession":"0001209191-14-067470","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-067470","line_url":"/filing/0001209191-14-067470#line-7","is_derivative":false,"issuer_cik":"0001201585","issuer_name":"Inogen Inc","issuer_ticker":"INGN","issuer_name_source":null,"issuer_url":"/issuer/0001201585","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Versant Side Fund II, LP; Bolzon Bradley J PhD; Versant Ventures II LLC; LUBASH BARBARA N; Warden Charles M; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4238.0,"shares_display":"4,238","price_per_share":24.5617,"price_display":"24.56","price_state":"stated","total_value":104092.4846,"total_display":"104,092.48","total_whole":"104,092","shares_owned_after":58495.0,"shares_owned_after_display":"58,495","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-11-06","filed_date":"2014-11-07","scope":"insider"},{"id":5674874,"accession":"0001209191-09-045187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-045187","line_url":"/filing/0001209191-09-045187#line-1","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"JAFFE ROSS A MD; Warden Charles M; LINK WILLIAM J PHD; Samuels Camille D; Bolzon Bradley J PhD; ROBERTSON REBECCA B; Versant Venture Capital II, LP","owner_display_name":"JAFFE ROSS A MD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":242931.0,"shares_display":"242,931","price_per_share":2.5728,"price_display":"2.57","price_state":"stated","total_value":625012.8768,"total_display":"625,012.88","total_whole":"625,013","shares_owned_after":10709818.0,"shares_owned_after_display":"10,709,818","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-18","filed_date":"2009-09-21","scope":"insider"},{"id":3618520,"accession":"0001209191-08-067548","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-067548","line_url":"/filing/0001209191-08-067548#line-3","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Versant Venture Capital II, LP; LINK WILLIAM J PHD; Samuels Camille D; JAFFE ROSS A MD; Warden Charles M; Bolzon Bradley J PhD","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8386581.0,"shares_display":"8,386,581","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":10466887.0,"shares_owned_after_display":"10,466,887","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":3618519,"accession":"0001209191-08-067548","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-067548","line_url":"/filing/0001209191-08-067548#line-2","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Versant Venture Capital II, LP; LINK WILLIAM J PHD; Samuels Camille D; JAFFE ROSS A MD; Warden Charles M; Bolzon Bradley J PhD","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":159154.0,"shares_display":"159,154","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":196522.0,"shares_owned_after_display":"196,522","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":3618518,"accession":"0001209191-08-067548","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-067548","line_url":"/filing/0001209191-08-067548#line-1","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"ROBERTSON REBECCA B; Versant Venture Capital II, LP; LINK WILLIAM J PHD; Samuels Camille D; JAFFE ROSS A MD; Warden Charles M; Bolzon Bradley J PhD","owner_display_name":"ROBERTSON REBECCA B","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":74955.0,"shares_display":"74,955","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":92533.0,"shares_owned_after_display":"92,533","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-12-23","filed_date":"2008-12-29","scope":"insider"},{"id":8507761,"accession":"0001209191-07-034581","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-034581","line_url":"/filing/0001209191-07-034581#line-4","is_derivative":false,"issuer_cik":"0001181338","issuer_name":"HELICOS BIOSCIENCES CORP","issuer_ticker":"HLCS","issuer_name_source":null,"issuer_url":"/issuer/0001181338","owner_cik":null,"owner_name":"Samuels Camille D; Warden Charles M; JAFFE ROSS A MD; Versant Ventures II LLC; LINK WILLIAM J PHD; Bolzon Bradley J PhD; ROBERTSON REBECCA B; Versant Side Fund II, LP; Versant Venture Capital II, LP; Versant Affiliates Fund II-A, LP","owner_display_name":"Samuels Camille D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":111111.0,"shares_display":"111,111","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":999999.0,"total_display":"999,999.00","total_whole":"999,999","shares_owned_after":111111.0,"shares_owned_after_display":"111,111","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-30","filed_date":"2007-06-01","scope":"insider"},{"id":5171354,"accession":"0001181431-06-030247","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-06-030247","line_url":"/filing/0001181431-06-030247#line-6","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"NOVACEA INC","issuer_ticker":"NOVC","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":null,"owner_name":"LINK WILLIAM J PHD; Bolzon Bradley J PhD; ROBERTSON REBECCA B; Warden Charles M","owner_display_name":"LINK WILLIAM J PHD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock, par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":230769.0,"shares_display":"230,769","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2044744.0,"shares_owned_after_display":"2,044,744","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-05-15","filed_date":"2006-05-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001419600","name":"Flexion Therapeutics Inc","url":"/issuer/0001419600","role":"Ten percent owner","n_filings":1,"first_seen":"2016-06-10","last_seen":"2016-06-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001429386","name":"PHASERX, INC.","url":"/issuer/0001429386","role":"Ten percent owner","n_filings":1,"first_seen":"2016-05-24","last_seen":"2016-05-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001393434","name":"OCULAR THERAPEUTIX, INC","url":"/issuer/0001393434","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2015-06-11","last_seen":"2015-06-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001294133","name":"Inogen Inc","url":"/issuer/0001294133","role":"Ten percent owner","n_filings":7,"first_seen":"2014-11-07","last_seen":"2015-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001274563","name":"HELICOS BIOSCIENCES CORP","url":"/issuer/0001274563","role":"Ten percent owner","n_filings":3,"first_seen":"2007-06-01","last_seen":"2009-09-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001178711","name":"NOVACEA INC","url":"/issuer/0001178711","role":"Ten percent owner","n_filings":1,"first_seen":"2006-05-15","last_seen":"2006-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001354802","retrieved_at":"2026-08-24T20:10:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}